POMT1 and muscular dystrophy-dystroglycanopathy, type A: A wide variety of ocular anomalies have been described in POMT1-related WWS and MEB patients including retinal malformations, vitreoretinal dysgenesis, optic nerve hypoplasia and blindness1,12–15.